semaglutide with medicaid Access to Wegovy limited in programs : Shots Bill could expand Medicaid access
Description
Positive cardiovascular outcomes would strengthen the case for dual agonism as a preferred therapeutic approach, particularly in high-risk patients
That loss of muscle can slow progress and make plateaus more likely
Clinical trials have strict eligibility criteria
What's the risk-benefit ratio
Randomised clinical trials must come first
How much weight can I lose on the maximum semaglutide dose
